112 related articles for article (PubMed ID: 33517812)
1. Simvastatin suppresses renal cell carcinoma cells by regulating DDX5/DUSP5.
Qiu Y; Zhao Y; Wang H; Liu W; Jin C; Xu W
Scand J Urol; 2021 Aug; 55(4):337-343. PubMed ID: 33517812
[TBL] [Abstract][Full Text] [Related]
2. P68 RNA helicase promotes invasion of glioma cells through negatively regulating DUSP5.
Wang R; Bao HB; Du WZ; Chen XF; Liu HL; Han DY; Wang LG; Wu JN; Wang CL; Yang MC; Liu ZW; Zhang N; Teng L
Cancer Sci; 2019 Jan; 110(1):107-117. PubMed ID: 30387548
[TBL] [Abstract][Full Text] [Related]
3. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis.
Zhao H; Xie Z; Tang G; Wei S; Chen G
J Cell Physiol; 2020 Oct; 235(10):6990-7002. PubMed ID: 31994189
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR, ERK and JAK2/STAT3 pathway.
Fang Z; Tang Y; Fang J; Zhou Z; Xing Z; Guo Z; Guo X; Wang W; Jiao W; Xu Z; Liu Z
PLoS One; 2013; 8(5):e62823. PubMed ID: 23690956
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5.
Chen Y; Liu X; Zhang F; Liao S; He X; Zhuo D; Huang H; Wu Y
PLoS One; 2018; 13(4):e0195844. PubMed ID: 29659618
[TBL] [Abstract][Full Text] [Related]
7. Jam3 promotes migration and suppresses apoptosis of renal carcinoma cell lines.
Li X; Yin A; Zhang W; Zhao F; Lv J; Lv J; Sun J
Int J Mol Med; 2018 Nov; 42(5):2923-2929. PubMed ID: 30226554
[TBL] [Abstract][Full Text] [Related]
8. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
[TBL] [Abstract][Full Text] [Related]
9. Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinoma.
Shang D; Han T; Xu X; Liu Y
Int J Clin Exp Pathol; 2015; 8(9):11140-8. PubMed ID: 26617834
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway.
Woschek M; Kneip N; Jurida K; Marzi I; Relja B
Nutr Cancer; 2016; 68(3):420-7. PubMed ID: 27042994
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-186 Suppresses Cell Proliferation and Metastasis Through Targeting Sentrin-Specific Protease 1 in Renal Cell Carcinoma.
Jiao D; Wu M; Ji L; Liu F; Liu Y
Oncol Res; 2018 Mar; 26(2):249-259. PubMed ID: 28550686
[TBL] [Abstract][Full Text] [Related]
12. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
13. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
Wang H; Chen B; Duan B; Zheng J; Wu X
Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
[TBL] [Abstract][Full Text] [Related]
14.
Lin TC
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326089
[TBL] [Abstract][Full Text] [Related]
15. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN.
Deng W; Han W; Fan T; Wang X; Cheng Z; Wan B; Chen J
Biomed Pharmacother; 2018 Nov; 107():1505-1513. PubMed ID: 30257368
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.
Liu Y; Cheng G; Huang Z; Bao L; Liu J; Wang C; Xiong Z; Zhou L; Xu T; Liu D; Yang H; Chen K; Zhang X
Cell Death Dis; 2020 Jul; 11(7):515. PubMed ID: 32641718
[TBL] [Abstract][Full Text] [Related]
17. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
Li Z; Ma Z; Xu X
Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
[TBL] [Abstract][Full Text] [Related]
18. LncRNA POU3F3 Promotes Cancer Cell Proliferation, Migration, and Invasion in Renal Cell Carcinoma by Downregulating LncRNA GAS5.
Zhang L; Wang C; Ma M
Kidney Blood Press Res; 2021; 46(5):613-619. PubMed ID: 34352801
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside compound K exerts antitumour effects in renal cell carcinoma via regulation of ROS and lncRNA THOR.
Chen S; Ye H; Gong F; Mao S; Li C; Xu B; Ren Y; Yu R
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649829
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.
Yamasaki T; Seki N; Yamada Y; Yoshino H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
Int J Oncol; 2012 Sep; 41(3):805-17. PubMed ID: 22766839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]